MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE

  • Darren J. Moore
    Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205;
  • Andrew B. West
    Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205;
  • Valina L. Dawson
    Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205;
  • Ted M. Dawson
    Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205;

説明

<jats:p> Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic neurons in the substantia nigra. Although the etiology of PD is incompletely understood, the recent discovery of genes associated with rare monogenic forms of the disease, together with earlier studies and new experimental animal models, has provided important and novel insight into the molecular pathways involved in disease pathogenesis. Increasing evidence indicates that deficits in mitochondrial function, oxidative and nitrosative stress, the accumulation of aberrant or misfolded proteins, and ubiquitin-proteasome system dysfunction may represent the principal molecular pathways or events that commonly underlie the pathogenesis of sporadic and familial forms of PD . </jats:p>

収録刊行物

被引用文献 (8)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ